Skip to content
10-K

Annual Report

Lazuriton Nano Biotechnology (U.S.A.) Inc.

0001640334-23-000748

← back to feed
Filed
May 3, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 9, 2023 100M sh
Operating Cash Flow FY 2021 · Dec 31, 2021 $0
Operating Cash Flow FY 2021 · Dec 31, 2020 $1
Stockholders Equity FY 2021 · Dec 31, 2021 −$368.58K
Stockholders Equity FY 2021 · Dec 31, 2020 −$319.78K
Stockholders Equity FY 2021 · Dec 31, 2019 −$268.54K
Current Liabilities FY 2021 · Dec 31, 2021 $369.93K
Current Liabilities FY 2021 · Dec 31, 2020 $321.13K
Total Liabilities FY 2021 · Dec 31, 2021 $369.93K
Total Liabilities FY 2021 · Dec 31, 2020 $321.13K
Current Assets FY 2021 · Dec 31, 2021 $1.35K
Current Assets FY 2021 · Dec 31, 2020 $1.35K
Total Assets FY 2021 · Dec 31, 2021 $1.35K
Total Assets FY 2021 · Dec 31, 2020 $1.35K
Sga Expense FY 2021 · Dec 31, 2021 $48.8K
Sga Expense FY 2021 · Dec 31, 2020 $51.24K
Net Income FY 2021 · Dec 31, 2021 −$48.8K
Net Income FY 2021 · Dec 31, 2020 −$51.24K
Operating Income FY 2021 · Dec 31, 2021 −$48.8K
Operating Income FY 2021 · Dec 31, 2020 −$51.24K
Revenue FY 2021 · Dec 31, 2021 $0
Revenue FY 2021 · Dec 31, 2020 $0